Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome

Clinical trial NCT01572636 · TERMINATED

Trial details

NCT number: NCT01572636
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Study type: OBSERVATIONAL

Mucopolysaccharidosis Type IH MPS I Hurler Syndrome

Start date: 2012-03-28
Primary completion: 2018-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.